# Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)

> **NCT04769414** · PHASE2 · COMPLETED · sponsor: **Menoufia University** · enrollment: 48 (actual)

## Conditions studied

- Cancer of Pancreas
- Chemotherapy Effect
- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine fluorouracil

## Key facts

- **NCT ID:** NCT04769414
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-20
- **Primary completion:** 2022-07-09
- **Final completion:** 2022-07-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769414, "Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04769414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*